Health Condition 1: null- DIAGNOSED CASE OF CA PROSTATE, ELIGIBLE FOR RADICAL RADIOTHERAPY
Conditions
Interventions
None listed
Sponsors
MedantaThe Medicity
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically proven prostate adenocarcinoma 2. Clinical stage T1-T3, N0-N1, M0 (Patients beyond T1-T2c will be taken after complete androgen blockade for 2 months 3. No prior radical surgery or cryosurgery for prostate cancer
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To quantitatively compare IMRT and VMAT techniques with regards to dosimetric quality and treatment delivery efficiency in the treatment of prostate cancers eligible to receive RT without violating the organ-at-risk constraints (OARs)Timepoint: To quantitatively compare IMRT and VMAT techniques with regards to dosimetric quality and treatment delivery efficiency in the treatment of prostate cancers eligible to receive RT without violating the organ-at-risk constraints (OARs) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the Normal tissue complication probability (NTCP) and Tumor control probability (TCP) by dose escalation with VMAT in terms of target coverage and sparing of organs at risk.Timepoint: One year. | — |
Countries
India
Contacts
Public ContactVIKASH KUMAR
Medanta Cancer Institute, Medanta-The Medicity.
Outcome results
None listed